Multifaceted roles of sphingosine-1-phosphate: How does this bioactive sphingolipid fit with acute neurological injury?

Journal of Neuroscience Research

Volumn 86, Issue 7, 2008, Pages 1419-1433

  Singh, Indrapal N ^a   Hall, Edward D ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Mitochondria; Sphingosine kinase; Sphingosine 1 phosphate; Spinal cord injury; Traumatic brain injury

Indexed keywords

ACYLSPHINGOSINE DEACYLASE; ADENYLATE CYCLASE; CERAMIDE; CYTOKINE; G PROTEIN COUPLED RECEPTOR; GROWTH FACTOR; HUMAN GROWTH HORMONE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHOLIPASE C; PHOSPHOLIPASE D; PROTEIN TYROSINE KINASE; RHO FACTOR; SPHINGOLIPID; SPHINGOMYELIN; SPHINGOMYELIN PHOSPHODIESTERASE; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE KINASE; STRESS ACTIVATED PROTEIN KINASE;

ANGIOGENESIS; APOPTOSIS; ASTROCYTOSIS; BRAIN INJURY; CELL DEATH; CELL DIFFERENTIATION; CELL FUNCTION; CELL MIGRATION; CELL PROTECTION; CELL SURVIVAL; ENZYME METABOLISM; ENZYME SYNTHESIS; HUMAN; LIPID HYDROLYSIS; LIPID METABOLISM; LIPOGENESIS; MITOCHONDRION; MITOGENESIS; NERVE FIBER GROWTH; NERVE REGENERATION; NERVOUS SYSTEM DEVELOPMENT; NEUROMODULATION; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR AFFINITY; REVIEW; SPINAL CORD INJURY; TANDEM MASS SPECTROMETRY; TRAUMATIC BRAIN INJURY;

ANIMALS; APOPTOSIS; CELL DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; HUMANS; LYSOPHOSPHOLIPIDS; NERVOUS SYSTEM DISEASES; SIGNAL TRANSDUCTION; SPHINGOLIPIDS; SPHINGOSINE;

EID: 43149110826     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.21586     Document Type: Review

References (136)

1. Altura BM, Gebrewold A, Zheng T, Altura BT. 2002. Sphingomyelinase and ceramide analogs induce vasoconstriction and leukocyte-endothelial interactions in cerebral venules in the intact rat brain: Insight into mechanisms and possible relation to brain injury and stroke. Brain Res Bull 58:271-278.
2. Anliker B, Chun J. 2004. Lysophospholipid G protein-coupled receptors. J Biol Chem 279:20555-20558.
3. Armstrong JS. 2006. The role of the mitochondrial permeability transition in cell death. Mitochondrion 6:225-234.
4. Balthasar S, Samulin J, Ahlgren H, Bergelin N, Lundqvist M, Toescu EC, Eggo MC, Tornquist K. 2006. Sphingosine 1-phosphate receptor expression profile and regulation of migration in human thyroid cancer cells. Biochem J 398:547-556.
5. Bektas M, Jolly PS, Muller C, Eberle J, Spiegel S, Geilen CC. 2005. Sphingosine kinase activity counteracts ceramide-mediated cell death in human melanoma cells: role of Bcl-2 expression. Oncogene 24:178-187.
6. Bernatchez PN, Tremblay F, Rollin S, Neagoe PE, Sirois MG. 2003. Sphingosine 1-phosphate effect on endothelial cell PAF synthesis: role in cellular migration. J Cell Biochem 90:719-731.
7. Betito S, Cuvillier O. 2006. Regulation by sphingosine 1-phosphate of Bax and Bad activities during apoptosis in a MEK-dependent manner. Biochem Biophys Res Commun 340:1273-1277.
8. Bionda C, Portoukalian J, Schmitt D, Rodriguez-Lafrasse C, Ardail D. 2004. Subcellular compartmentalization of ceramide metabolism: MAM (mitochondria-associated membrane) and/or mitochondria? Biochem J 382:527-533.
9. Birbes H, El Bawab S, Hannun YA, Obeid LM. 2001. Selective hydrolysis of a mitochondrial pool of sphingomyelin induces apoptosis. FASEB J 15:2669-2679.
10. Bischoff A, Czyborra P, Meyer Zu Heringdorf D, Jakobs KH, Michel MC. 2000. Sphingosine-1-phosphate reduces rat renal and mesenteric blood flow in vivo in a pertussis toxin-sensitive manner. Br J Pharmacol 130:1878-1883.
11. Brinkmann V, Lynch KR. 2002. FTY720: targeting G-protein-coupled receptors for sphingosine 1-phosphate in transplantation and autoimmunity. Curr Opin Immunol 14:569-575.
12. Brinkmann V, Davis MD, Heise CE, Albert R, Cottens S, Hof R, Bruns C, Prieschl E, Baumruker T, Hiestand P, Foster CA, Zollinger M, Lynch KR. 2002. The immune modulator FTY720 targets sphingosine 1-phosphate receptors. J Biol Chem 277:21453-21457.
13. Brizuela L, Rabano M, Gangoiti P, Narbona N, Macarulla JM, Trueba M, Gomez-Munoz A. 2007. Sphingosine 1-phosphate stimulates aldosterone secretion through a mechanism involving the PI3-kinase/PKB and MEK/ERK 1/2 pathways. J Lipid Res.
14. Chalfant CE, Spiegel S. 2005. Sphingosine 1-phosphate and ceramide 1-phosphate: expanding roles in cell signaling. J Cell Sci 118:4605-4612.
15. Chun J. 1999. Lysophospholipid receptors: implications for neural signaling. Crit Rev Neurobiol 13:151-168.
16. Cuvillier O. 2002. Sphingosine in apoptosis signaling. Biochim Biophys Acta 1585:153-162.
17. Cuvillier O, Levade T. 2001. Sphingosine 1-phosphate antagonizes apoptosis of human leukemia cells by inhibiting release of cytochrome c and Smac/Diablo from mitochondria. Blood 98:2828-2836.
18. Cuvillier O, Nava VE, Murthy SK, Edsall LC, Levade T, Milstien S, Spiegel S. 2001. Sphingosine generation, cytochrome c release, and activation of caspase-7 in doxorubicin-induced apoptosis of MCF7 breast adenocarcinoma cells. Cell Death Differ 8:162-171.
19. Dai Q, Liu J, Chen J, Durrant D, McIntyre TM, Lee RM. 2004. Mitochondrial ceramide increases in UV-irradiated HeLa cells and is mainly derived from hydrolysis of sphingomyelin. Oncogene 23:3650-3658.
20. Dantas AP, Igarashi J, Michel T. 2003. Sphingosine 1-phosphate and control of vascular tone. Am J Physiol Heart Circ Physiol 284:H2045-2052.
21. Davaille J, Li L, Mallat A, Lotersztajn S. 2002. Sphingosine 1-phosphate triggers both apoptotic and survival signals for human hepatic myofibroblasts. J Biol Chem 277:37323-37330.
22. Dimmeler S, Fleming I, Fisslthaler B, Hermann C, Busse R, Zeiher AM. 1999. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 399:601-605.
23. Dudek SM, Jacobson JR, Chiang ET, Birukov KG, Wang P, Zhan X, Garcia JG. 2004. Pulmonary endothelial cell barrier enhancement by sphingosine 1-phosphate: roles for cortactin and myosin light chain kinase. J Biol Chem 279:24692-24700.
24. Eigenbrod S, Derwand R, Jakl V, Endres S, Eigler A. 2006. Sphingosine kinase and sphingosine-1-phosphate regulate migration, endocytosis and apoptosis of dendritic cells. Immunol Invest 35:149-165.
25. El-Shewy HM, Johnson KR, Lee MH, Jaffa AA, Obeid LM, Luttrell LM. 2006. Insulin-like growth factors mediate heterotrimeric G protein-dependent ERK1/2 activation by transactivating sphingosine 1-phosphate receptors. J Biol Chem 281:31399-31407.
26. English D, Welch Z, Kovala AT, Harvey K, Volpert OV, Brindley DN, Garcia JG. 2000. Sphingosine 1-phosphate released from platelets during clotting accounts for the potent endothelial cell chemotactic activity of blood serum and provides a novel link between hemostasis and angiogenesis. FASEB J 14:2255-2265.
27. Farooqui AA, Horrocks LA. 2006. Phospholipase A2-generated lipid mediators in the brain: the good, the bad, and the ugly. Neuroscientist 12:245-260.
28. Farooqui AA, Horrocks LA, Farooqui T. 2007. Interactions between neural membrane glycerophospholipid and sphingolipid mediators: a recipe for neural cell survival or suicide. J Neurosci Res 85:1834-1850.
29. Folkman J. 1995. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1:27-31.
30. Fulton D, Gratton JP, McCabe TJ, Fontana J, Fujio Y, Walsh K, Franke TF, Papapetropoulos A, Sessa WC. 1999. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 399:597-601.
31. Gahm C, Danilov A, Holmin S, Wiklund PN, Brundin L, Mathiesen T. 2005. Reduced neuronal injury after treatment with NG-nitro-L-arginine methyl ester (L-NAME) or 2-sulfo-phenyl-N-tert-butyl nitrone (S-PBN) following experimental brain contusion. Neurosurgery 57: 1272-1281; discussion 1272-1281.
32. Garcia JG, Liu F, Verin AD, Birukova A, Dechert MA, Gerthoffer WT, Bamberg JR, English D. 2001. Sphingosine 1-phosphate promotes endothelial cell barrier integrity by Edg-dependent cytoskeletal rearrangement. J Clin Invest 108:689-701.
33. Garcia-Ruiz C, Colell A, Mari M, Morales A, Fernandez-Checa JC. 1997. Direct effect of ceramide on the mitochondrial electron transport chain leads to generation of reactive oxygen species. Role of mitochondrial glutathione. J Biol Chem 272:11369-11377.
34. Giussani P, Maceyka M, Le Stunff H, Mikami A, Lepine S, Wang E, Kelly S, Merrill AH Jr, Milstien S, Spiegel S. 2006. Sphingosine-1-phosphate phosphohydrolase regulates endoplasmic reticulum-to-golgi trafficking of ceramide. Mol Cell Biol 26:5055-5069.
35. Giussani P, Ferraretto A, Gravaghi C, Bassi R, Tettamanti G, Riboni L, Viani P. 2007. Sphingosine-1-phosphate and calcium signaling in cerebellar astrocytes and differentiated granule cells. Neurochem Res 32:27-37.
36. Goetzl EJ, Kong Y, Mei B. 1999. Lysophosphatidic acid and sphingosine 1-phosphate protection of T cells from apoptosis in association with suppression of Bax. J Immunol 162:2049-2056.
37. Gomez-Munoz A, Kong J, Salh B, Steinbrecher UP. 2003. Sphingosine-1-phosphate inhibits acid sphingomyelinase and blocks apoptosis in macrophages. FEBS Lett 539:56-60.
38. Hall ED. 1995. Inhibition of lipid peroxidation in central nervous system trauma and ischemia. J Neurol Sci 134(Suppl):79-83.
39. Hall ED, Springer JE. 2004. Neuroprotection and acute spinal cord injury: a reappraisal. NeuroRx 1:80-100.
40. Hall ED, Kupina NC, Althaus JS. 1999. Peroxynitrite scavengers for the acute treatment of traumatic brain injury. Ann N Y Acad Sci 890:462-468.
41. Hall ED, Detloff MR, Johnson K, Kupina NC. 2004. Peroxynitrite-mediated protein nitration and lipid peroxidation in a mouse model of traumatic brain injury. J Neurotrauma 21:9-20.
42. Hallbergson AF, Gnatenco C, Peterson DA. 2003. Neurogenesis and brain injury: managing a renewable resource for repair. J Clin Invest 112:1128-1133.
43. Halliwell B. 2007. Oxidative stress and cancer: have we moved forward? Biochem J 401:1-11.
44. Harada J, Foley M, Moskowitz MA, Waeber C. 2004. Sphingosine-1-phosphate induces proliferation and morphological changes of neural progenitor cells. J Neurochem 88:1026-1039.
45. Hla T. 2004. Physiological and pathological actions of sphingosine 1-phosphate. Semin Cell Dev Biol 15:513-520.
46. Huang P, Frohman MA. 2007. The potential for phospholipase D as a new therapeutic target. Expert Opin Ther Targets 11:707-716.
47. Idzko M, Panther E, Corinti S, Morelli A, Ferrari D, Herouy Y, Dichmann S, Mockenhaupt M, Gebicke-Haerter P, Di Virgilio F, Girolomoni G, Norgauer J. 2002. Sphingosine 1-phosphate induces chemotaxis of immature and modulates cytokine-release in mature human dendritic cells for emergence of Th2 immune responses. FASEB J 16:625-627.
48. Jiang X, Han X. 2006. Characterization and direct quantitation of sphingoid base-1-phosphates from lipid extracts: a shotgun lipidomics approach. J Lipid Res 47:1865-1873.
49. Jin JK, Kim NH, Min DS, Kim JI, Choi KJ, Jeong BH, Choi SI, Choi EK, Carp RI, Kim YS. 2005. Increased expression of phospholipase D1 in the brains of scrapie-infected mice. J Neurochem 92:452-461.
50. Johnson KR, Becker KP, Facchinetti MM, Hannun YA, Obeid LM. 2002. PKC-dependent activation of sphingosine kinase 1 and translocation to the plasma membrane. Extracellular release of sphingosine-1-phosphate induced by phorbol 12-myristate 13-acetate (PMA). J Biol Chem 277:35257-35262.
51. Jung K, Min DS, Sim KB, Ahn M, Kim H, Cheong J, Shin T. 2003. Up-regulation of phospholipase D1 in the spinal cords of rats with clip compression injury. Neurosci Lett 336:126-130.
52. Kimura A, Ohmori T, Ohkawa R, Madoiwa S, Mimuro J, Murakami T, Kobayashi E, Hoshino Y, Yatomi Y, Sakata Y. 2007. Essential roles of sphingosine 1-phosphate/S1P1 receptor axis in the migration of neural stem cells toward a site of spinal cord injury. Stem Cells 25:115-124.
53. Kohama T, Olivera A, Edsall L, Nagiec MM, Dickson R, Spiegel S. 1998. Molecular cloning and functional characterization of murine sphingosine kinase. J Biol Chem 273:23722-23728.
54. Kono M, Mi Y, Liu Y, Sasaki T, Allende ML, Wu YP, Yamashita T, Proia RL. 2004. The sphingosine-1-phosphate receptors S1P1, S1P2, and S1P3 function coordinately during embryonic angiogenesis. J Biol Chem 279:29367-29373.
55. Kroemer G, Dallaporta B, Resche-Rigon M. 1998. The mitochondrial death/life regulator in apoptosis and necrosis. Annu Rev Physiol 60:619-642.
56. Kwon YG, Min JK, Kim KM, Lee DJ, Billiar TR, Kim YM. 2001. Sphingosine 1-phosphate protects human umbilical vein endothelial cells from serum-deprived apoptosis by nitric oxide production. J Biol Chem 276:10627-10633.
57. Lee MJ, Thangada S, Paik JH, Sapkota GP, Ancellin N, Chae SS, Wu M, Morales-Ruiz M, Sessa WC, Alessi DR, Hla T. 2001. Akt-mediated phosphorylation of the G protein-coupled receptor EDG-1 is required for endothelial cell chemotaxis. Mol Cell 8:693-704.
58. Lee MY, Kim SY, Min DS, Choi YS, Shin SL, Chun MH, Lee SB, Kim MS, Jo YH. 2000. Up-regulation of phospholipase D in astrocytes in response to transient forebrain ischemia. Glia 30:311-317.
59. Lee OH, Kim YM, Lee YM, Moon EJ, Lee DJ, Kim JH, Kim KW, Kwon YG. 1999. Sphingosine 1-phosphate induces angiogenesis: is angiogenic action and signaling mechanism in human umbilical vein endothelial cells. Biochem Biophys Res Commun 264:743-750.
60. Lee SB, Bae IH, Bae YS, Um HD. 2006. Link between mitochondria and NADPH oxidase 1 isozyme for the sustained production of reactive oxygen species and cell death. J Biol Chem 281:36228-36235.
61. Lifshitz J, Sullivan PG, Hovda DA, Wieloch T, McIntosh TK. 2004. Mitochondrial damage and dysfunction in traumatic brain injury. Mitochondrion 4:705-713.
62. Limaye V, Li X, Hahn C, Xia P, Berndt MC, Vadas MA, Gamble JR. 2005. Sphingosine kinase-1 enhances endothelial cell survival through a PECAM-1-dependent activation of PI-3K/Akt and regulation of Bcl-2 family members. Blood 105:3169-3177.
63. Liu H, Sugiura M, Nava VE, Edsall LC, Kono K, Poulton S, Milstien S, Kohama T, Spiegel S. 2000. Molecular cloning and functional characterization of a novel mammalian sphingosine kinase type 2 isoform. J Biol Chem 275:19513-19520.
64. Liu H, Chakravarty D, Maceyka M, Milstien S, Spiegel S. 2002. Sphingosine kinases: a novel family of lipid kinases. Prog Nucleic Acid Res Mol Biol 71:493-511.
65. Lorenz JN, Arend LJ, Robitz R, Paul RJ, MacLennan AJ. 2007. Vascular dysfunction in S1P2 sphingosine 1-phosphate receptor knockout mice. Am J Physiol Regul Integr Comp Physiol 292:R440-R446.
66. Maceyka M, Payne SG, Milstien S, Spiegel S. 2002. Sphingosine kinase, sphingosine-1-phosphate, and apoptosis. Biochim Biophys Acta 1585: 193-201.
67. Maceyka M, Sankala H, Hait NC, Le Stunff H, Liu H, Toman R, Collier C, Zhang M, Satin LS, Merrill AH Jr, Milstien S, Spiegel S. 2005. SphK1 and SphK2, sphingosine kinase isoenzymes with opposing functions in sphingolipid metabolism. J Biol Chem 280:37118-37129.
68. Maceyka M, Milstien S, Spiegel S. 2007. Shooting the messenger: oxidative stress regulates sphingosine-1-phosphate. Circ Res 100:7-9.
69. Madesh M, Ramachandran A, Pulimood A, Vadranam M, Balasubramanian KA. 2000. Attenuation of intestinal ischemia/reperfusion injury with sodium nitroprusside: studies on mitochondrial function and lipid changes. Biochim Biophys Acta 1500:204-216.
70. Mandala SM. 2001. Sphingosine-1-phosphate phosphatases. Prostaglandins Other Lipid Mediat 64:143-156.
71. Mather M, Rottenberg H. 2000. Aging enhances the activation of the permeability transition pore in mitochondria. Biochem Biophys Res Commun 273:603-608.
72. McGiffert C, Contos JJ, Friedman B, Chun J. 2002. Embryonic brain expression analysis of lysophospholipid receptor genes suggests roles for s1p(1) in neurogenesis and s1p(1-3) in angiogenesis. FEBS Lett 531:103-108.
73. Milne GL, Morrow JD. 2006. Isoprostanes and related compounds: update 2006. Antioxid Redox Signal 8:1379-1384.
74. Mitra P, Maceyka M, Payne SG, Lamour N, Milstien S, Chalfant CE, Spiegel S. 2007. Ceramide kinase regulates growth and survival of A549 human lung adenocarcinoma cells. FEBS Lett 581:735-740.
75. Mizugishi K, Yamashita T, Olivera A, Miller GF, Spiegel S, Proia RL. 2005. Essential role for sphingosine kinases in neural and vascular development. Mol Cell Biol 25:11113-11121.
76. Nava VE, Cuvillier O, Edsall LC, Kimura K, Milstien S, Gelmann EP, Spiegel S. 2000. Sphingosine enhances apoptosis of radiation-resistant prostate cancer cells. Cancer Res 60:4468-4474.
77. Nava VE, Hobson JP, Murthy S, Milstien S, Spiegel S. 2002. Sphingosine kinase type 1 promotes estrogen-dependent tumorigenesis of breast cancer MCF-7 cells. Exp Cell Res 281:115-127.
78. Nitahara JA, Cheng W, Liu Y, Li B, Leri A, Li P, Mogul D, Gambert SR, Kajstura J, Anversa P. 1998. Intracellular calcium, DNase activity and myocyte apoptosis in aging Fischer 344 rats. J Mol Cell Cardiol 30:519-535.
79. Nofer JR, van der Giet M, Tolle M, Wolinska I, von Wnuck Lipinski K, Baba HA, Tietge UJ, Godecke A, Ishii I, Kleuser B, Schafers M, Fobker M, Zidek W, Assmann G, Chun J, Levkau B. 2004. HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3. J Clin Invest 113:569-581.
80. O'Donnell VB, Chumley PH, Hogg N, Bloodsworth A, Darley-Usmar VM, Freeman BA. 1997. Nitric oxide inhibition of lipid peroxidation: kinetics of reaction with lipid peroxyl radicals and comparison with alpha-tocopherol. Biochemistry 36:15216-15223.
81. Ogawa C, Kihara A, Gokoh M, Igarashi Y. 2003. Identification and characterization of a novel human sphingosine-1-phosphate phosphohydrolase, hSPP2. J Biol Chem 278:1268-1272.
82. Ogretmen B, Hannun YA. 2004. Biologically active sphingolipids in cancer pathogenesis and treatment. Nat Rev Cancer 4:604-616.
83. Olivera A, Kohama T, Tu Z, Milstien S, Spiegel S. 1998. Purification and characterization of rat kidney sphingosine kinase. J Biol Chem 273:12576-12583.
84. Orrenius S, Gogvadze V, Zhivotovsky B. 2007. Mitochondrial oxidative stress: implications for cell death. Annu Rev Pharmacol Toxicol 47:143-183.
85. Paik JH, Chae S, Lee MJ, Thangada S, Hla T. 2001. Sphingosine 1-phosphate-induced endothelial cell migration requires the expression of EDG-1 and EDG-3 receptors and Rho-dependent activation of alpha vbeta3- and beta1-containing integrins. J Biol Chem 276:11830-11837.
86. Pchejetski D, Kunduzova O, Dayon A, Calise D, Seguelas MH, Leducq N, Seif I, Parini A, Cuvillier O. 2007. Oxidative stress-dependent sphingosine kinase-1 inhibition mediates monoamine oxidase A-associated cardiac cell apoptosis. Circ Res 100:41-49.
87. Pebay A, Toutant M, Premont J, Calvo CF, Venance L, Cordier J, Glowinski J, Tence M. 2001a. Antiproliferative properties of sphingosine-1-phosphate in human hepatic myofibroblasts. Eur J Neurosci 13:2067-2076.
88. Pebay A, Toutant M, Premont J, Calvo CF, Venance L, Cordier J, Glowinski J, Tence M. 2001b. Sphingosine-1-phosphate induces proliferation of astrocytes: regulation by intracellular signalling cascades. Eur J Neurosci 13:2067-2076.
89. Pettus BJ, Bielawski J, Porcelli AM, Reames DL, Johnson KR, Morrow J, Chalfant CE, Obeid LM, Hannun YA. 2003. The sphingosine kinase 1/sphingosine-1-phosphate pathway mediates COX-2 induction and PGE2 production in response to TNF-alpha. FASEB J 17:1411-1421.
90. Pitson SM, Xia P, Leclercq TM, Moretti PA, Zebol JR, Lynn HE, Wattenberg BW, Vadas MA. 2005. Phosphorylation-dependent translocation of sphingosine kinase to the plasma membrane drives its oncogenic signalling. J Exp Med 201:49-54.
91. Postma FR, Jalink K, Hengeveld T, Moolenaar WH. 1996. Sphingosine-1-phosphate rapidly induces Rho-dependent neurite retraction: action through a specific cell surface receptor. EMBO J 15:2388-2392.
92. Pyne S, Pyne NJ. 2000. Sphingosine 1-phosphate signalling in mammalian cells. Biochem J 349:385-402.
93. Pyne S, Pyne NJ. 2002. Sphingosine 1-phosphate signalling and termination at lipid phosphate receptors. Biochim Biophys Acta 1582:121-131.
94. Pyne S, Kong KC, Darroch PI. 2004. Lysophosphatidic acid and sphingosine 1-phosphate biology: the role of lipid phosphate phosphatases. Semin Cell Dev Biol 15:491-501.
95. Quillet-Mary A, Jaffrezou JP, Mansat V, Bordier C, Naval J, Laurent G. 1997. Implication of mitochondrial hydrogen peroxide generation in ceramide-induced apoptosis. J Biol Chem 272:21388-21395.
96. Radeff-Huang J, Seasholtz TM, Chang JW, Smith JM, Walsh CT, Brown JH. 2007. Tumor necrosis factor-alpha-stimulated cell proliferation is mediated through sphingosine kinase-dependent Akt activation and cyclin D expression. J Biol Chem 282:863-870.
97. Raymond MN, Bole-Feysot C, Banno Y, Tanfin Z, Robin P. 2006. Endothelin-1 inhibits apoptosis through a sphingosine kinase 1-dependent mechanism in uterine leiomyoma ELT3 cells. Endocrinology 147:5873-5882.
98. Reddy PH. 2006. Amyloid precursor protein-mediated free radicals and oxidative damage: implications for the development and progression of Alzheimer's disease. J Neurochem 96:1-13.
99. Rosen H, Goetzl EJ. 2005. Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network. Nat Rev Immunol 5:560-570.
100. Rubbo H, Radi R, Anselmi D, Kirk M, Barnes S, Butler J, Eiserich JP, Freeman BA. 2000. Nitric oxide reaction with lipid peroxyl radicals spares alpha-tocopherol during lipid peroxidation. Greater oxidant protection from the pair nitric oxide/alpha-tocopherol than alpha-tocopherol/ascorbate. J Biol Chem 275:10812-10818.
101. Saba JD, Hla T. 2004. Point-counterpoint of sphingosine 1-phosphate metabolism. Circ Res 94:724-734.
102. Saini HS, Coelho RP, Goparaju SK, Jolly PS, Maceyka M, Spiegel S, Sato-Bigbee C. 2005. Novel role of sphingosine kinase 1 as a mediator of neurotrophin-3 action in oligodendrocyte progenitors. J Neurochem 95:1298-1310.
103. Salomone S, Yoshimura S, Reuter U, Foley M, Thomas SS, Moskowitz MA, Waeber C. 2003. S1P3 receptors mediate the potent constriction of cerebral arteries by sphingosine-1-phosphate. Eur J Pharmacol 469:125-134.
104. Sanchez T, Thangada S, Wu MT, Kontos CD, Wu D, Wu H, Hla T. 2005. PTEN as an effector in the signaling of antimigratory G protein-coupled receptor. Proc Natl Acad Sci U S A 102:4312-4317.
105. Sarkar S, Maceyka M, Hait NC, Paugh SW, Sankala H, Milstien S, Spiegel S. 2005. Sphingosine kinase 1 is required for migration, proliferation and survival of MCF-7 human breast cancer cells. FEBS Lett 579:5313-5317.
106. Scheek S, Brown MS, Goldstein JL. 1997. Sphingomyelin depletion in cultured cells blocks proteolysis of sterol regulatory element binding proteins at site 1. Proc Natl Acad Sci U S A 94:11179-11183.
107. Schwab SR, Pereira JP, Matloubian M, Xu Y, Huang Y, Cyster JG. 2005. Lymphocyte sequestration through S1P lyase inhibition and disruption of S1P gradients. Science 309:1735-1739.
108. Sen T, Sen N, Tripathi G, Chatterjee U, Chakrabarti S. 2006. Lipid peroxidation associated cardiolipin loss and membrane depolarization in rat brain mitochondria. Neurochem Int 49:20-27.
109. Shimomura I, Shimano H, Korn BS, Bashmakov Y, Horton JD. 1998. Nuclear sterol regulatory element-binding proteins activate genes responsible for the entire program of unsaturated fatty acid biosynthesis in transgenic mouse liver. J Biol Chem 273:35299-35306.
110. Singh IN, Sullivan PG, Deng Y, Mbye LH, Hall ED. 2006. Time course of post-traumatic mitochondrial oxidative damage and dysfunction in a mouse model of focal traumatic brain injury: implications for neuroprotective therapy. J Cereb Blood Flow Metab 26:1407-1418.
111. Spiegel S, Kolesnick R. 2002. Sphingosine 1-phosphate as a therapeutic agent. Leukemia 16:1596-1602.
112. Spiegel S, Milstien S. 2003. Sphingosine-1-phosphate: an enigmatic signalling lipid. Nat Rev Mol Cell Biol 4:397-407.
113. i pathways integrated downstream of a single G protein-coupled sphingosine-1-phosphate receptor isoform. Mol Cell Biol 23: 1534-1545.
114. Sugiyama A, Yatomi Y, Ozaki Y, Hashimoto K. 2000. Sphingosine 1-phosphate induces sinus tachycardia and coronary vasoconstriction in the canine heart. Cardiovasc Res 46:119-125.
115. Sullivan PG. 2005. Interventions with neuroprotective agents: novel targets and opportunities. Epilepsy Behav 7(Suppl 3):S12-S17.
116. Taha TA, Kitatani K, El-Alwani M, Bielawski J, Hannun YA, Obeid LM. 2006a. Loss of sphingosine kinase-1 activates the intrinsic pathway of programmed cell death: modulation of sphingolipid levels and the induction of apoptosis. FASEB J 20:482-484.
117. Taha TA, Mullen TD, Obeid LM. 2006b. A house divided: ceramide, sphingosine, and sphingosine-1-phosphate in programmed cell death. Biochim Biophys Acta 1758:2027-2036.
118. Taha TE, Brown ER, Hoffman IF, Fawzi W, Read JS, Sinkala M, Martinson FE, Kafulafula G, Msamanga G, Emel L, Adeniyi-Jones S, Goldenberg R. 2006c. A phase III clinical trial of antibiotics to reduce chorioamnionitis-related perinatal HIV-1 transmission. AIDS 20:1313-1321.
119. Takeda S, Mitsutake S, Tsuji K, Igarashi Y. 2006. Apoptosis occurs via the ceramide recycling pathway in human HaCaT keratinocytes. J Biochem (Tokyo) 139:255-262.
120. Tao R, Zhang J, Vessey DA, Honbo N, Karliner JS. 2007. Deletion of the sphingosine kinase-1 gene influences cell fate during hypoxia and glucose deprivation in adult mouse cardiomyocytes. Cardiovasc Res 74:56-63.
121. Tellier E, Negre-Salvayre A, Bocquet B, Itohara S, Hannun YA, Salvayre R, Auge N. 2007. Role for furin in tumor necrosis factor alpha-induced activation of the matrix metalloproteinase/sphingolipid mitogenic pathway. Mol Cell Biol 27:2997-3007.
122. Van Brocklyn JR, Tu Z, Edsall LC, Schmidt RR, Spiegel S. 1999. Sphingosine 1-phosphate-induced cell rounding and neurite retraction are mediated by the G protein-coupled receptor H218. J Biol Chem 274:4626-4632.
123. Van Brocklyn JR, Jackson CA, Pearl DK, Kotur MS, Snyder PJ, Prior TW. 2005. Sphingosine kinase-1 expression correlates with poor survival of patients with glioblastoma multiforme: roles of sphingosine kinase isoforms in growth of glioblastoma cell lines. J Neuropathol Exp Neurol 64:695-705.
124. Vann LR, Payne SG, Edsall LC, Twitty S, Spiegel S, Milstien S. 2002. Involvement of sphingosine kinase in TNF-alpha-stimulated tetrahydrobiopterin biosynthesis in C6 glioma cells. J Biol Chem 277:12649-12656.
125. Venkataraman K, Thangada S, Michaud J, Oo ML, Ai Y, Lee YM, Wu M, Parikh NS, Khan F, Proia RL, Hla T. 2006. Extracellular export of sphingosine kinase-1a contributes to the vascular S1P gradient. Biochem J 397:461-471.
126. Wada K, Chatzipanteli K, Kraydieh S, Busto R, Dietrich WD. 1998. Inducible nitric oxide synthase expression after traumatic brain injury and neuroprotection with aminoguanidine treatment in rats. Neurosurgery 43:1427-1436.
127. i-coupled cell surface receptor. Potential involvement in angiogenesis. J Biol Chem 274:35343-35350.
128. Weigert A, Johann AM, von Knethen A, Schmidt H, Geisslinger G, Brune B. 2006. Apoptotic cells promote macrophage survival by releasing the antiapoptotic mediator sphingosine-1-phosphate. Blood 108: 1635-1642.
129. Won JS, Singh I. 2006. Sphingolipid signaling and redox regulation. Free Rad Biol Med 40:1875-1888.
130. Worgall TS, Johnson RA, Seo T, Gierens H, Deckelbaum RJ. 2002. Unsaturated fatty acid-mediated decreases in sterol regulatory element-mediated gene transcription are linked to cellular sphingolipid metabolism. J Biol Chem 277:3878-3885.
131. Yasui H, Hideshima T, Raje N, Roccaro AM, Shiraishi N, Kumar S, Hamasaki M, Ishitsuka K, Tai YT, Podar K, Catley L, Mitsiades CS, Richardson PG, Albert R, Brinkmann V, Chauhan D, Anderson KC. 2005. FTY720 induces apoptosis in multiple myeloma cells and overcomes drug resistance. Cancer Res 65:7478-7484.
132. Yatomi Y, Yamamura S, Ruan F, Igarashi Y. 1997. Sphingosine 1-phosphate induces platelet activation through an extracellular action and shares a platelet surface receptor with lysophosphatidic acid. J Biol Chem 272:5291-5297.
133. Yavin E. 2006. Versatile roles of docosahexaenoic acid in the prenatal brain: from pro- and anti-oxidant features to regulation of gene expression. Prostaglandins Leukot Essent Fatty Acids 75:203-211.
134. Yedgar S, Cohen R, Gatt S, Barenholz Y. 1982. Hydrolysis of monomolecular layers of synthetic sphingomyelins by sphingomyelinase of Staphylococcus aureus. Biochem J 201:597-603.
135. Zemann B, Kinzel B, Muller M, Reuschel R, Mechtcheriakova D, Urtz N, Bornancin F, Baumruker T, Billich A. 2006. Sphingosine kinase type 2 is essential for lymphopenia induced by the immunomodulatory drug FTY720. Blood 107:1454-1458.
136. Zheng DM, Kitamura T, Ikejima K, Enomoto N, Yamashina S, Suzuki S, Takei Y, Sato N. 2006. Sphingosine 1-phosphate protects rat liver sinusoidal endothelial cells from ethanol-induced apoptosis: role of intracellular calcium and nitric oxide. Hepatology 44:1278-1287.